In the study of drug-resistance mechanisms, most of the current studies have focused on the classical mechanisms of the MDR gene and the P-gp encoded by the MDR gene, while few studies have focused on non-classical mechanisms such as GST-π, Topo II, DNA damage repair, and tumor stem cells. This evidence concerns the gene GSTP1 and neoplasm.